Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: BCC Research | PRODUCT CODE: 1396663

Cover Image

PUBLISHER: BCC Research | PRODUCT CODE: 1396663

Neurology Devices: Global Markets

PUBLISHED:
PAGES: 102 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4650
PDF & Excel (2-5 Users)
USD 5580
PDF & Excel (Site License)
USD 6696
PDF & Excel (Enterprise License)
USD 8035

Add to Cart

Highlights:

The global market for neurology devices is estimated to increase from $23.7 billion in 2023 to reach $31.7 billion by 2028, at a compound annual growth rate (CAGR) of 6.0% from 2023 through 2028.

The global market for neurosurgical devices is estimated to increase from $7.5 billion in 2023 to reach $9.6 billion by 2028, at a compound annual growth rate (CAGR) of 5.1% from 2023 through 2028.

The global market for neurovascular devices is estimated to increase from $5.9 billion in 2023 to reach $8.9 billion by 2028, at a compound annual growth rate (CAGR) of 8.7% from 2023 through 2028.

Report Scope:

This report is a comprehensive study of the global market for neurology devices. It describes the neurology devices market and segments it by product type and region. Based on product type, the market is segmented into neurosurgical devices, neuromodulation devices, neurovascular devices and neurodiagnostic devices. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific and Rest of the World (RoW).

This report examines the factors driving growth in the neurology devices market, and it reviews major players, established companies, and new entrants.

In this report, the neurosurgical devices segment covers neurosurgical instruments, neurosurgery support devices/equipment, such as surgical microscopes, surgery navigation systems, and in the neurodiagnostic segment CT. MRI scanners are also considered as their role is prominent in the diagnosis of brain tumors and for radiosurgery applications. The revenue estimations are done for CT and MRI scans based on the neurology application point of view rather than the sales of the devices in this segment. The report does not cover neuro diagnostic assays, biomarker assays and related IVD instruments. It is purely focused on clinical applications, not research-oriented ones.

Report Includes:

  • 20 data tables and 18 additional tables
  • An overview of the global markets for neurology devices
  • In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
  • Evaluation of the current market size and revenue growth prospects specific to neurology devices, accompanied by a comprehensive market share analysis categorized by product type, and geographical region
  • Discussion on the emerging technologies in neurology devices market and areas of focus to forecast the market into various segments and sub-segments
  • Assessment of the key drivers and constraints that will shape the market for neurology devices and discussion on the upcoming market opportunities
  • Detailed description of the competitive landscape, product mapping, major player's strategic initiatives, R&D activities, and other initiatives
  • Detailed profiles of leading market participants, including Medtronic, Abbott, Terumo, Boston Scientific Corp., Natus Medical Inc., and Siemens Healthineers
Product Code: MDS096A

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Information Sources
  • Primary Research
  • Secondary Research
  • Geographic Breakdown
  • Segmentation Breakdown

Chapter 2 Summary and Highlights

  • Market Outlook
  • Highlights of the Neurology Devices Market

Chapter 3 Market Background and Definitions

  • Overview
  • Neurology Devices
  • Neurosurgical Devices
  • Neuromodulation Devices
  • Neurovascular Devices
  • Neurodiagnostic Equipment
  • Diseases Background
  • Stroke
  • Parkinson's Disease
  • Alzheimer's Disease
  • Epilepsy and Seizures
  • Carotid Artery Disease
  • Cerebral Aneurysms
  • Tremors
  • Multiple Sclerosis
  • Depression

Chapter 4 Market Trends

  • Market Drivers
  • Aging Population
  • Neurology Disorders and Cancer Cases by Country
  • Penetration of Neurology Devices in Emerging Markets
  • Market Opportunity
  • Market Restraints

Chapter 5 Market Breakdown by Product Type

  • Overview
  • Neurosurgical Devices
  • Neuromodulation Devices
  • Neurovascular Devices
  • Neurodiagnostic Devices

Chapter 6 Market Breakdown by Region

  • Overview
  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 7 Emerging Trends/Technologies in the Neurology Devices Market

  • Overview
  • AI in Neurology
  • Wearable Neurology Devices
  • Precision Radiotherapy in Neurology
  • Stereotactic Radiosurgery
  • Stereotactic Body Radiation Therapy
  • Brain-Computer Interfaces (BCIs)

Chapter 8 Sustainability in Neurology Devices Market: An ESG Perspective

  • Overview
  • Introduction to ESG
  • Environmental Factors
  • Social Factors
  • Governance Factors
  • Neurology Devices Market ESG Performance Analysis by Company
  • Consumer Attitude Towards ESG in the Neurology Devices Market
  • Conclusion

Chapter 9 Pipeline Analysis

  • Clinical Trials Scenario

Chapter 10 Competitive Landscape

  • Industry Scenario
  • Company Shares

Chapter 11 Company Profiles

  • ABBOTT
  • AXONICS INC.
  • BOSTON SCIENTIFIC CORP.
  • B. BRAUN SE
  • DANAHER CORP.
  • ELEKTA
  • GE HEALTHCARE
  • INTEGRA LIFESCIENCES
  • JOHNSON & JOHNSON SERVICES INC.
  • KONINKLIJKE PHILIPS N.V.
  • LIVANOVA PLC
  • MEDTRONIC PLC
  • NATUS MEDICAL INC.
  • NEVRO CORP.
  • NIHON KOHDEN CORP.
  • PENUMBRA INC.
  • STRYKER CORP.
  • SIEMENS HEALTHCARE GMBH
  • TERUMO MEDICAL CORP.

Chapter 12 Appendix: Acronyms

Product Code: MDS096A

List of Tables

  • Summary Table : Global Market for Neurology Devices, by Product Type, Through 2028
  • Table 1 : Global Population, Aged 60 Years and Older, 2017-2050
  • Table 2 : Prevalent Cases of Brain and Central Nervous System Cancer, by Country, 2015-2030
  • Table 3 : Prevalent Cases of Parkinson's Disease, by Country, 2015-2030
  • Table 4 : Prevalent Cases of Ischemic Stroke, by Country, 2015-2030
  • Table 5 : Prevalent Cases of Idiopathic Epilepsy, by Country, 2015-2030
  • Table 6 : Prevalent Cases of Alzheimer's and Dementia, by Country, 2015-2030
  • Table 7 : Global Market for Neurology Devices, by Product Type, Through 2028
  • Table 8 : Global Market for Neurosurgical Devices, by Region, Through 2028
  • Table 9 : Global Market for Neuromodulation Devices, by Region, Through 2028
  • Table 10 : Global Market for Neurovascular Devices, by Region, Through 2028
  • Table 11 : Global Market for Neurodiagnostic Devices, by Region, Through 2028
  • Table 12 : Global Market for Neurology Devices, by Region, Through 2028
  • Table 13 : North American Market for Neurology Devices, by Country, Through 2028
  • Table 14 : Latin American Market for Neurology Devices, by Country, Through 2028
  • Table 15 : European Market for Neurology Devices, by Country, Through 2028
  • Table 16 : Asia-Pacific Market for Neurology Devices, by Country, Through 2028
  • Table 17 : RoW Market for Neurology Devices, Through 2028
  • Table 18 : Medtronic: ESG Performance
  • Table 19 : Medtronic: ESG Goals
  • Table 20 : Abbott: ESG Performance
  • Table 21 : Terumo: ESG Performance
  • Table 22 : Selected Neuromodulation Devices in Clinical Trials, as of 2023
  • Table 23 : Abbott: Neurostimulation Product Portfolio
  • Table 24 : Axonics Inc.: News, 2023
  • Table 25 : Axonics Inc.: Product Portfolio
  • Table 26 : Boston Scientific Corp.: News, 2023
  • Table 27 : Boston Scientific Corp.: Product Portfolio
  • Table 28 : B. Braun Se: Neurodevice Product Portfolio
  • Table 29 : Danaher Corp.: Company Financials, 2022
  • Table 30 : Danaher Corp.: Product Portfolio
  • Table 31 : Elekta: Product Portfolio
  • Table 32 : Natus Medical Inc.: Product Portfolio
  • Table 33 : Nihon Kohden Corp.: Product Portfolio
  • Table 34 : Penumbra Inc: Neurovascular Product Portfolio
  • Table 35 : Stryker: Business Segments
  • Table 36 : Siemens Healthineers: Product Portfolio
  • Table 37 : Acronyms Used in this Report

List of Figures

  • Summary Figure A : Global Market for Neurology Devices, by Product Type, 2020-2028
  • Summary Figure B : Global Market Shares of Neurology Devices, by Product Type, 2022
  • Figure 1 : Global Market for Neurology Devices, by Product Type, 2020-2028
  • Figure 2 : Global Market Shares of Neurology Devices, by Product Type, 2022
  • Figure 3 : Global Market for Neurosurgical Devices, by Region, 2020-2028
  • Figure 4 : Global Market for Neuromodulation Devices, by Region, 2020-2028
  • Figure 5 : Global Market for Neurovascular Devices, by Region, 2020-2028
  • Figure 6 : Global Market for Neurodiagnostic Devices, by Region, 2020-2028
  • Figure 7 : Global Market Shares of Neurology Devices, by Region, 2022
  • Figure 8 : North American Market Shares of Neurology Devices, by Country, 2022
  • Figure 9 : Latin American Market Shares of Neurology Devices, by Country, 2022
  • Figure 10 : European Market Shares of Neurology Devices, by Country, 2022
  • Figure 11 : Asia-Pacific Market Shares of Neurology Devices, by Country, 2022
  • Figure 12 : Emerging Trends and Technologies in the Neurology Devices Market
  • Figure 13 : Medtronic: Greenhouse Gas Emissions, 2020-2022
  • Figure 14 : Medtronic: Water Use, 2020-2022
  • Figure 15 : Medtronic: Total Waste Generated, 2020-2022
  • Figure 16 : Global Neurology Devices, Company Share, 2022
  • Figure 17 : Global Neurosurgical Devices, Company Share, 2022
  • Figure 18 : Global Neuromodulation Devices, Company Share, 2022
  • Figure 19 : Global Neurovascular Devices, Company Share, 2022
  • Figure 20 : Global Neurodiagnostic Devices, Company Share, 2022
  • Figure 21 : Abbott: Diagnostics Division, Net Revenue, 2020-2022
  • Figure 22 : Abbott: Market Share, by Business Segment, 2022
  • Figure 23 : Axonics Inc.: Net Revenue, 2020-2022
  • Figure 24 : Axonics Inc.: Market Share, by Business Segment, 2022
  • Figure 25 : Axonics Inc.: Sales Share, by Region, 2022
  • Figure 26 : Boston Scientific Corp.: Net Revenue, 2020-2022
  • Figure 27 : Boston Scientific Corp.: Market Share, by Business Segment, 2022
  • Figure 28 : B. Braun Se: Net Revenue, 2020-2022
  • Figure 29 : Danaher Corp.: Revenue Share, by Business Segment, 2022
  • Figure 30 : Danaher Corp.: Revenue Share, by Region, 2022
  • Figure 31 : Integra LifeSciences: Net Revenue, 2020-2022
  • Figure 32 : Integra LifeSciences: Market Share, by Business Segment, 2022
  • Figure 33 : LivaNova Plc: Neuromodulation Sales Share, by Region, 2022
  • Figure 34 : Nevro Corp.: Net Revenue, 2020-2022
  • Figure 35 : Nevro Corp.: Sales Share, by Region, 2022
  • Figure 36 : Penumbra: Net Revenue, 2020-2022
  • Figure 37 : Penumbra: Neuro Products Revenue, 2020-2022
  • Figure 38 : Stryker: Net Revenue, 2020-2022
  • Figure 39 : Stryker: Market Share, by Business Segment, 2022
  • Figure 40 : Siemens Healthineers: Net Revenue, 2020-2022
  • Figure 41 : Siemens Healthineers: Market Share, by Business Segment, 2022
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!